Leonteq Securities AG’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-20,000
Closed -$1.13M 1250
2024
Q4
$1.13M Hold
20,000
0.08% 220
2024
Q3
$1.03M Hold
20,000
0.08% 206
2024
Q2
$831K Hold
20,000
0.06% 228
2024
Q1
$1.08M Sell
20,000
-35,000
-64% -$1.78M 0.08% 213
2023
Q4
$2.82M Buy
+55,000
New +$2.89M 0.16% 127

Other funds holding BMY

Leonteq Securities AG's BMY Position: Q2 2026 in Review

Leonteq Securities AG reduced its Bristol-Myers Squibb (BMY) stake by 89% in Q2 2026, selling an estimated $5.74M and leaving 12,628 shares worth $728K. The position accounts for 0.03% of the portfolio, ranked #320.

Leonteq Securities AG first reported a position in BMY in Q1 2021 and has held it in 19 quarters since. The position peaked at $6.83M in Q1 2026. 949 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Leonteq Securities AG held 12,628 shares of Bristol-Myers Squibb worth $728K as of Q2 2026.
  • Leonteq Securities AG sold 100,037 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.74M.
  • Bristol-Myers Squibb made up 0.03% of Leonteq Securities AG's portfolio in Q2 2026, its #320 holding.
  • Leonteq Securities AG first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 19 quarters since.
  • Leonteq Securities AG's Bristol-Myers Squibb position peaked at $6.83M in Q1 2026.
  • 949 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.